Key result
Analysis of 15 angiosarcoma cases revealed no EGFR or MET amplification, frequent hyperploidy, and an aggressive clinical course for epithelioid and metal-associated tumors.
Observational (n=15)
EGFR and MET amplification are unlikely to play a role in the biology of angiosarcoma, though hyperploidy and monosomy related to chromosome 7 copy number alterations are present.
EGFR/MET inhibitors unlikely to benefit angiosarcoma; case series leaves open hyperploidy as prognostic marker.
Background: Angiosarcomas (AS) are high-grade sarcomas that comprise less than 1% of soft tissue sarcomas. We compared clinical, pathological and molecular features of primary and recurrent conventional AS, including cases occurring in unusual backgrounds, such as organ transplants, at a site of metal orthopedic implant, and at a site of prior trauma. Materials and Methods: Paraffin blocks from 15 patients with AS were retrieved from our archives. Ten patients had recurrent AS, 4 patients had metastases. AS were morphologically categorized them into epithelioid and conventional types. Immunohistochemical stains included three vascular markers, cytokeratins, Akt, Ki67, HHV8 and EBV in paired samples of primary and recurrent/metastatic AS. Fluorescence In Situ Hybridization (FISH) analysis for Epidermal Growth Factor Receptor (EGFR) and Hepatocyte Growth Factor Receptor (MET) was performed on all AS samples. Results: Conventional AS were positive for more than two vascular markers and negative for cytokeratins. Epithelioid AS demonstrated variable positivity for vascular markers and cytokeratins. All tumors were negative for HHV8 and EBV. All AS displayed cytoplasmic immunopositivity for the phosphorylated forms of Akt. Conclusion: AS with epithelioid features had fewer positive vascular markers, possibly reflecting a lack of differentiation. There were no differences in pattern of immunoreactivity between post-transplant and conventional AS and primary and metastatic AS. No amplification of either EGFR or MET was found but a majority of the cases demonstrated hyperploidy and three cases demonstrated monosomy for EGFR in greater than 50% of cells. Both MET and EGFR are located on chromosome 7 and the detected hyperploidy and monosomy of these two genes are likely related to copy number alterations of chromosome 7. It is unlikely that these two genes play a role in biology of AS. AS with epithelioid features and metal associated AS, which are extremely rare, had an aggressive clinical course.
No takes yet. Share an insight, caveat, or question.
Bibianna Purgina (2014) conducted an observational in Angiosarcoma of soft tissue and bone (n=15). Angiosarcoma subtype and clinical background was evaluated on Immunohistochemical and molecular features including EGFR and MET amplification. Analysis of 15 angiosarcoma cases revealed no EGFR or MET amplification, frequent hyperploidy, and an aggressive clinical course for epithelioid and metal-associated tumors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: